Nav: Home

Researchers identify 'beige' fat-burning cells in humans

March 31, 2015

For the first time, a research team, led by a UC San Francisco biologist, has isolated energy-burning "beige" fat from adult humans, which is known to be able to convert unhealthy white fat into healthy brown fat. The scientists also found new genetic markers of this beige fat.

The discovery is an important advance in the search for new medications to fight obesity, said senior investigator Shingo Kajimura, PhD, UCSF assistant professor of cell and tissue biology, with a joint appointment in the UCSF Diabetes Center and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF.

The finding was published online on March 16, 2015 in Nature Medicine.

All mammals, including humans, have two types of fat with completely opposite functions: white, which stores energy and is linked with diabetes and obesity, and brown, which produces heat by burning energy and is associated with leanness. Human babies are born with brown fat as a natural defense against cold, and hibernating animals such as bears build up large stores of brown fat for the same reason.

Since 2009, explained Kajimura, it's been known that adult humans also have significant amounts of brown fat. But until now, it had not been known whether this fat is the so-called classical brown fat of the type that babies are born with, or beige fat, which is found within white fat and has the ability to convert, or recruit, white fat into brown fat in response to cold or other stresses.

To answer that question, Kajimura and his team isolated and cloned single brown fat cells from two adult individuals. After sophisticated genetic and protein analyses of the cloned cells, they concluded that they had successfully isolated recruitable brown fat.

"This finding brings us another step closer to the goal of our laboratory, which is engineering fat cells to fight obesity," said Kajimura. "We are trying to learn how to convert white fat into brown fat, and until now, it had not been demonstrated that this recruitable form of brown fat is actually present in humans."

Now that they have a reliable human beige fat cell culture system, Kajimura said, his team will be able to use the system as a screening platform to identify and test small molecules that activate the development, differentiation, and thermogenic (heat-producing) activity of human brown fat.

The ultimate aim, he said, is the creation of drugs to turn white fat into brown fat through brown fat recruitment.

"If you think about obesity, it's generally caused by an imbalance between energy intake and energy expenditure," Kajimura said. "So far, all of the approved anti-obesity medications reduce energy intake by decreasing appetite. They work in the short term, but they often have side effects such as depression. If we have a compound that increases energy expenditure by recruiting new brown fat and activating brown fat thermogenesis, then it might work synergistically with conventional anti-obesity medications. This would be a novel approach to modulating whole-body energy balance."
-end-
Co-authors of the study are Kosaku Shinoda, PhD, Ineke H. N. Luijten, Yutaka Hasegawa, MD, PhD, Haemin Hong, Si B. Sonne, PhD, and Miae Kim, PhD, of UCSF; Ruidan Xue PhD, of Joslin Diabetes Center (JBS) and Harvard Medical School (HMS); Maria Chondronikola of Shriners Hospital for Children (SHC) and University of Texas (UT); Aaron M Cypess, MD, PhD, and Yu-Hua Tseng, PhD, of JBS and HMS; Jan Nedergaard, PhD, of Stockholm University, Sweden; and Labros S. Sidossis, PhD, of SHC and UT.

The study was supported by funds from the National Institutes of Health, Pew Charitable Trust, Japan Science and Technology Agency, Japan Society for the Promotion of Science, and Manpei Suzuki Diabetes Foundation.

UCSF is the nation's leading university exclusively focused on health. Now celebrating the 150th anniversary of its founding as a medical college, UCSF is dedicated to transforming health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with world-renowned programs in the biological sciences, a preeminent biomedical research enterprise and two top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco. Please visit http://www.ucsf.edu.

University of California - San Francisco

Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Nina
Producer Tracie Hunte stumbled into a duet between Nina Simone and the sounds of protest outside her apartment. Then she discovered a performance by Nina on April 7, 1968 - three days after the assassination of Dr. Martin Luther King Jr. Tracie talks about what Nina's music, born during another time when our country was facing questions that seemed to have no answer, meant then and why it still resonates today.  Listen to Nina's brother, Samuel Waymon, talk about that April 7th concert here.